Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)
Launched by TUFTS MEDICAL CENTER · Apr 7, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Presents with ocular surface discomfort or for dry eye care
- • Best corrected visual acuity of 20/40 or better in each eye
- • Subject reported duration of symptoms of at least 3 months
- • 100 subjects will be required to be habitual contact lens wearers as defined by use of contact lenses at least 5 hours per day at least 5 days per week for the last year.
- Exclusion Criteria:
- • Use of contact lenses on the day of the visit
- • Pregnant or nursing
- • Irregular corneas (e.g., ectatic disease, transplantation, or corneal dystrophies)
- • Ocular surgery in the past 3 months
- • Ocular infection in the past 3 months
- • Active ocular allergies
About Tufts Medical Center
Tufts Medical Center is a leading academic medical institution located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a sponsor of clinical trials, Tufts Medical Center leverages its expertise in diverse medical disciplines to develop and test new therapies, enhance patient care, and contribute to the scientific community. With a focus on collaboration and rigorous methodologies, the center aims to translate research findings into practical applications that improve health outcomes for patients locally and globally. Its dedication to excellence is reflected in its partnerships with academic institutions, industry leaders, and healthcare organizations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Baltimore, Maryland, United States
Iowa City, Iowa, United States
Chicago, Illinois, United States
Boston, Massachusetts, United States
Austin, Texas, United States
Saint Louis, Missouri, United States
Denver, Colorado, United States
Pomona, California, United States
Pittsburg, Kansas, United States
Fort Lauderdale, Florida, United States
Chicago, Illinois, United States
Westlake, Ohio, United States
Shelby, North Carolina, United States
Azusa, California, United States
San Francisco, California, United States
Miami, Florida, United States
Boston, Massachusetts, United States
Saint Louis, Missouri, United States
Buffalo, New York, United States
Edmond, Oklahoma, United States
New Holland, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Shrewsbury, Pennsylvania, United States
Memphis, Tennessee, United States
Patients applied
Trial Officials
Pedram Hamrah, MD
Principal Investigator
Tufts Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials